ALK-Abelló
A pharmaceutical company specializing in allergy prevention, diagnosis, and treatment.
ALK | CO
Overview
Corporate Details
- ISIN(s):
- DK0061802139
- LEI:
- 529900SGCREUZCZ7P020
- Country:
- Denmark
- Address:
- Bøge Alle 6-8, 2970 Hørsholm
- Website:
- https://www.alk.net
- Sector:
- Manufacturing
Description
ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2017-03-07 15:43 | Danish | TXT • 7.2 KB | |||
| 2017-03-07 15:43 | English | TXT • 7.3 KB | |||
| 2017-03-07 15:43 |
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyt…
|
English | PDF • 33.9 KB | ||
| 2017-03-07 15:43 |
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyt…
|
English | PDF • 33.9 KB | ||
| 2017-03-06 15:57 | Danish | TXT • 3.6 KB | |||
| 2017-03-06 15:57 | English | PDF • 22.9 KB | |||
| 2017-03-06 15:56 |
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyt…
|
English | PDF • 23.0 KB | ||
| 2017-03-06 15:56 |
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyt…
|
English | TXT • 3.6 KB | ||
| 2017-03-01 23:02 | English | TXT • 3.9 KB | |||
| 2017-03-01 23:02 | Danish | TXT • 3.9 KB | |||
| 2017-03-01 23:02 |
FDA godkender ALKs tabletvaccine mod husstøvmideallergi (ACARIZAX® i Europa)
|
English | PDF • 33.2 KB | ||
| 2017-03-01 23:02 |
FDA godkender ALKs tabletvaccine mod husstøvmideallergi (ACARIZAX® i Europa)
|
English | PDF • 33.4 KB | ||
| 2017-02-16 08:27 | Danish | TXT • 3.7 KB | |||
| 2017-02-16 08:27 | English | TXT • 3.6 KB | |||
| 2017-02-16 08:27 |
ALK indsender registreringsansøgning for tabletvaccinen mod ragweedallergi i Eu…
|
English | PDF • 180.5 KB |
Automate Your Workflow. Get a real-time feed of all ALK-Abelló filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ALK-Abelló
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ALK-Abelló via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
